Complexities of cancer research: Mouse genetic models

ILAR Journal

Volumn 43, Issue 2, 2002, Pages 80-88

  Hunter, Kent W ^a   Williams, Robert W ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Cancer; Genetics; Modifiers; QTLs; Susceptibility

Indexed keywords

ANIMAL; CHROMOSOME MAP; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; MOUSE; NEOPLASM; PATHOPHYSIOLOGY; PEDIGREE; REVIEW;

ANIMALS; CHROMOSOME MAPPING; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; NEOPLASMS; PEDIGREE;

EID: 0036366670     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.43.2.80     Document Type: Article

References (67)

1. Bailey D. 1981. Recombinant inbred strains and bilineal congenic strains. In: Foster H, Small J, Fox J, eds. The Mouse in Biomedical Research. Vol 1. New York: Academic Press. p 223-239.
2. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup, JM, vanTuinen P, Ledbetter DH, Barker DF, Nakamura Y, White R, Vogelstein B. 1989. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244:217-221.
3. Belknap JK. 1998. Effect of within-strain sample size on QTL detection and mapping using recombinant inbred mouse strains. Behav Genet 28:29-38.
4. Belknap JK, Mitchell SR, O'Toole LA, Helms ML, Crabbe JC. 1996. Type I and type II error rates for quantitative trait loci (QTL) mapping studies using recombinant inbred mouse strains. Behav Genet 26:149-160.
5. Belknap J, Hitzemann R, Crabbe J, Phillips T, Buck K, Williams R. 2001. QTL analysis and genome-wide mutagenesis in mice: Complementary genetic approaches to the dissection of complex traits. Behav Genet 31:5-15.
6. Bolivar VJ, Cook MN, Flaherty L. 2001. Mapping of quantitative trait loci with knockout/congenic strains. Genome Res 11:1549-1552.
7. Chen TM, Defendi V. 1992. Functional interaction of p53 with HPV18 E6, c-myc and H-ras in 3T3 cells. Oncogene 7:1541-1547.
8. Darvasi A. 1998. Experimental strategies for the genetic dissection of complex traits in animal models. Nat Genet 18:19-24.
9. Dehal P, Predki P, Olsen AS, Kobayashi A, Folta P, Lucas S, Land M, Terry A, Ecale Zhou CL, Rash S, Zhang Q, Gordon L, Kim J, Elkin C, Pollard MJ, Richardson P, Rokhsar D, Uberbacher E, Hawkins T, Branscomb E, Stubbs L. 2001. Human chromosome 19 and related regions in mouse: Conservative and lineage-specific evolution. Science 293:104-111.
10. Demant P, Hart AA. 1986. Recombinant congenic strains - A new tool for analyzing genetic traits determined by more than one gene. Immunogenetics 24:416-422.
11. Dragani TA, Peissel B, Zanesi N, Aloisi A, Dai Y, Kato M, Suzuki H, Nakashima I. 2000. Mapping of melanoma modifier loci in RET transgenic mice. Jpn J Cancer Res 91:1142-1147.
12. Dryja TP, Friend S, Weinberg RA. 1986. Genetic sequences that predispose to retinoblastoma and osteosarcoma. Symp Fund Cancer Res 39: 115-119.
13. Dunning,AM, Durocher F, Healey CS, Teare MD, McBride SE, Carlomagno F, Xu CF, Dawson E, Rhodes S, Ueda S, Lai E, Luben RN, Van Rensburg EJ, Mannermaa A, Kataja V, Rennart G, Dunham I, Purvis I, Easton D, Ponder BA. 2000. The extent of linkage disequilibrium in four populations with distinct demographic histories. Am J Hum Genet 67:1544-1554.
14. Eliyahu D, Michalovitz D, Eliyahu S, Pinhasi-Kimhi O, Oren M. 1989. Wild-type p53 can inhibit oncogene-mediated focus formation. Proc Natl Acad Sci U S A 86:8763-8767.
15. Fijneman RJ, de Vries SS, Jansen RC, Demant P. Complex interactions of new quantitative trait loci, Slucl, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat Genet 14:465-467.
16. Fijneman RJ, Jansen RC, van der Valk MA, Demant P. 1998. High frequency of interactions between lung cancer susceptibility genes in the mouse: Mapping of Sluc5 to Slucl4. Cancer Res 58:4794-4798.
17. Fijneman RJ, van der Valk MA, Demant P. 1998. Genetics of quantitative and qualitative aspects of lung tumorigenesis in the mouse: Multiple interacting susceptibility to lung cancer (Sluc) genes with large effects. Exp Lung Res 24:419-436.
18. Finlay CA, Hinds PW, Levine AJ. 1989. The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083-1093.
19. Fortin A, Diez E, Rochefort D, Laroche L, Malo D, Rouleau GA, Gros P, Skamene E. 2001. Recombinant congenic strains derived from a/j and c57bl/6j: A tool for genetic dissection of complex traits. Genomics 74:21-35.
20. Graff RJ, Hildemann WH, Snell GD. 1966. Histocompatibility genes of mice. VI. Allografts in mice congenic at various non-H-2 histocompatibility loci. Transplantation 4:425-437.
21. Grisel JE, Belknap JK, O'Toole LA, Helms ML, Wenger CD, Crabbe JC. 1997. Quantitative trait loci affecting methamphetamine responses in BXD recombinant inbred mouse strains. J Neurosci 17:745-754.
22. Groot P, Moen C, Hart A, Snoek M, Demant P. 1996. Recombinant congenic strains - Genetic composition. In: Lyons M, Rastan S, Brown S, eds. Genetic Variations and Strains of the Laboratory Mouse. Vol. 2. New York: Oxford University Press. p 1660-1670. ,
23. Gutmann DH. 1994. New insights into the neurofibromatoses. Curr Opin Neurol 7:166-171.
24. Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC, Housman DE. 1990. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 61:1257-1269.
25. Hrabe de Angelis MH, Flaswinkel H, Fuchs H, Rathkolb B, Soewarto D, Marschall S, Heffner S, Pargent W, Wuensch K, Jung M, Reis A, Richter T, Alessandrini F, Jakob T, Fuchs E, Kolb H, Kremmer E, Schaeble K, Rollinski B, Roscher A, Peters C, Meitinger T, Strom T, Steekler T, Holsboer F, Klopstock T, Gekeler F, Schindewolf C, Jung T, Avraham K, Behrendt H, Ring J, Zimmer A, Schughart K, Pfeffer K, Wolf E, Balling R. 2000. Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet 25:444-447.
26. Huebner RJ, Todaro GJ. 1969. Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci U S A 64:1087-1094.
27. Hunter K, Broman K, LeVoyer T, Lukes L, Cozma D, Debies M, Rouse J, Welch D. 2002. Predisposition to efficient mammary tumor metastasis progression is linked to the breast cancer metastasis suppressor gene Brms1. Cancer Res (In Press).
28. Ihrig M, Schrenzel MD, Fox JG. 1999. Differential susceptibility to hepatic inflammation and proliferation in AXB recombinant inbred mice chronically infected with Helicobacter hepaticus. Am J Pathol 155: 571-582.
29. Klein RF, Mitchell SR, Phillips TJ, Belknap JK, Orwoll ES. 1998. Quantitative trait loci affecting peak bone mineral density in mice. J Bone Min Res 13:1648-1656.
30. Knudson AG Jr, Hethcote HW, Brown BW. 1975. Mutation and childhood cancer: A probabilistic model for the incidence of retinoblastoma. Proc Natl Acad Sci U S A 72:5116-5120.
31. Kruglyak L. 1999. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 22:139-144.
32. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann N, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny M, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, J. H. Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blocker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussier D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowski J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, Szustakowki J. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
33. Le Voyer T, Lu Z, Babb J, Lifsted T, Williams M, Hunter K. 2000. An epistatic interaction controls the latency of a transgene-induced mammary tumor. Mamm Genome 11:883-889.
34. Le Voyer T, Rouse J, Lu Z, Lifsted T, Williams M, Hunter K. 2001. Three loci modify growth of a transgene-induced mammary tumor: Suppression of proliferation associated with decreased microvessel density. Genomics 74:253-261.
35. Lee GH, Drinkwater NR. 1995. Hepatocarcinogenesis in BXH recombinant inbred strains of mice: Analysis of diverse phenotypic effects of the hepatocarcinogen sensitivity loci. Mol Carcinogr 14:190-197.
36. Levine AJ. 1989. The p53 tumor suppressor gene and gene product. Princess Takamatsu Symp 20:221-230.
37. Liu HX, Cartegni L, Zhang MQ, Krainer AR. 2001. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 27:55-58.
38. Lowe SW, Ruley HE, Jacks T, Housman DE. 1993. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967.
39. MacPhee M, Chepenik KP, Liddell RA, Nelson KK, Siracusa LD, Buchberg AM. 1995. The secretory phospholipase A2 gene is a candidate for the Moml locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell 81:957-966.
40. Markel P, Shu P, Ebeling C, Carlson GA, Nagle DL, Smutko JS, Moore KJ. 1997. Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains. Nat Genet 17:280-284.
41. Mock BA, Krall MM, Dosik JK. 1993. Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis. Proc Natl Acad Sci U S A 90:9499-9503.
42. Morel L, Blenman KR, Croker BP, Wakeland EK. 2001. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc Natl Acad Sci U S A 98:1787-1792.
43. Moser AR, Hegge LF, Cardiff RD. 2001. Genetic background affects susceptibility to mammary hyperplasias and carcinomas in Apc(min)/+ mice. Cancer Res 61:3480-3485.
44. Nadeau JH, Frankel WN. 2000. The roads from phenotypic variation to gene discovery: Mutagenesis versus QTLs. Nat Genet 25:381-384.
45. Nadeau JH, Singer JB, Matin A, Lander ES. 2000. Analysing complex genetic traits with chromosome substitution strains. Nat Genet 24:221-225.
46. Nagase H, Mao JH, de Koning JP, Minami T, Balmain A. 2001. Epistatic interactions between skin tumor modifier loci in interspecific (spretus/ musculus) backcross mice. Cancer Res 61:1305-1308.
47. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modall R, Harris CC, Vogelstein B. 1989. Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705-708.
48. Nolan PM, Peters J, Vizor L, Strivens M, Washbourne R, Hough T, Wells C, Glenister P, Thornton C, Martin J, Fisher E, Rogers D, Hagan J, Reavill C, Gray I, Wood J, Spurr N, Browne M, Rastan S, Hunter J, Brown SD. 2000. Implementation of a large-scale ENU mutagenesis program: Towards increasing the mouse mutant resource. Mamm Genome 11:500-506.
49. Pataer A, Nishimura M, Kamoto T, Ichioka K, Sato M, Hiai H. 1997. Genetic resistance to urethan-induced pulmonary adenomas in SMXA recombinant inbred mouse strains. Cancer Res 57:2904-2908.
50. Picksley SM, Spicer JF, Barnes DM, Lane DP. 1996. The p53-MDM2 interaction in a cancer-prone family, and the identification of a novel therapeutic target. Acta Oncol 35:429-434.
51. Potter M, Mushinski EB, Wax JS, Hartley J, Mock BA. 1994. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice. Cancer Res 54:969-975.
52. Riese U, Dahse R, Fiedler W, Theuer C, Koscielny S, Ernst G, Beleites E, Claussen U, von Eggeling F. 1999. Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancer. Int J Mol Med 4:61-65.
53. Rowse GJ, Ritland SR, Gendler SJ. 1998. Genetic modulation of neu proto-oncogene-induced mammary tumorigenesis. Cancer Res 58: 2675-2679.
54. Sandberg R, Yasuda R, Pankratz DG, Carter TA, Del Rio JA, Wodicka L, Mayford M, Lockhart DJ, Barlow C. 2000. Regional and strain-specific gene expression mapping in the adult mouse brain. Proc Natl Acad Sci U S A 97:11038-11043.
55. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines G, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y. 1995. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753.
56. Scherf M, Klingenhoff A, Frech K, Quandt K, Schneider R, Grote K, Frisch M, Gailus-Durner V, Seidel A, Brack-Werner R, Werner T. 1996. First pass annotation of promoters on human chromosome 22. Genome Res 11:333-340.
57. Sherr CJ. Cancer cell cycles. Science 274:1672-1677.
58. Stanbridge EJ. 1989. The evidence for human tumor suppressor genes. Princess Takamatsu Symp 20:3-13.
59. Stockwell BR. 2000. Chemical genetics: Ligand-based discovery of gene function. Nat Rev Genet 1:116-125.
60. Stoll M, Kwitek-Black AE, Cowley AW Jr, Harris EL, Harrap SB, Krieger JE, Printz MP, Provoost AP, Sassard J, Jacob HJ. 2000. New target regions for human hypertension via comparative genomics. Genome Res 10:473-482.
61. Tafti M, Chollet D, Valatx JL, Franken P. 1999. Quantitative trait loci approach to the genetics of sleep in recombinant inbred mice. J Sleep Res 8(Suppl 1):37-43.
62. Taylor B. Recombinant inbred strains. In: Lyon M, Rastan S, Brown S, eds. 1996. Genetic Variations and Strains of the Laboratory Mouse. Vol 2. New York: Oxford University Press, p 1597-1659.
63. Todaro GJ, Huebner RJ. 1972. The viral oncogene hypothesis: New evidence. Proc Natl Acad Sci U S A 69:1009-1015.
64. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD, Amanatides P, Ballew, RM, Huson DH, Wortman JR, Zhang Q, Kodira CD, Zheng XH, Chen L, Skupski M, Subramanian G, Thomas PD, Zhang J, Gabor Miklos GL, Nelson C, Broder S, Clark AG, Nadeau J, McKusick VA, Zinder N, Levine AJ, Roberts RJ, Simon M, Slayman C, Hunkapiller M, Bolanos R, Delcher A, Dew I, Fasulo D, Flanigan M, Florea L, Halpern A, Hannenhalli S, Kravitz S, Levy S, Mobarry C, Reinert K, Remington K, Abu-Threideh J, Beasley E, Biddick K, Bonazzi V, Brandon R, Cargill M, Chandramouliswaran I, Charlab R, Chaturvedi K, Deng Z, Di Francesco V, Dunn P., Eilbeck K, Evangelista C, Gabrielian AE, Can W, Ge W, Gong F, Gu Z, Guan P, Heiman TJ, Higgins ME, Ji RR, Ke Z, Ketchum KA, Lai Z, Lei Y, Li Z, Li J, Liang Y, Lin X, Lu F, Merkulov GV, Milshina N, Moore HM, Naik AK, Narayan VA, Neelam B, Nusskern D, Rusch DB, Salzberg S, Shao W, Shue B, Sun J, Wang Z, Wang A, Wang X, Wang J, Wei M, Wides R, Xiao C, Yan C, Yao A, Ye J, Zhan M, Zhang W, Zhang H, Zhao Q, Zheng L, Zhong F, Zhong W, Zhu S, Zhao S, Gilbert D, Baumhueter S, Spier G, Carter C, Cravchik A, Woodage T, Ali F, An H, Awe A, Baldwin D, Baden H, Barnstead M, Barrow I, Beeson K, Busam D, Carver A, Center A, Cheng ML, Curry L, Danaher S, Davenport L, Desilets R, Dietz S, Dodson K, Doup L, Ferriera S, Garg N, Gluecksmann A, Hart B, Haynes J, Haynes C, Heiner C, Hladun S, Hostin D, Houck J, Howland T, Ibegwam C, Johnson J, Kalush F, Kline L, Koduru S, Love A, Mann F, May D, McCawley S, McIntosh T, McMullen I, Moy M, Moy L, Murphy B, Nelson K, Pfannkoch C, Pratts E, Puri V, Qureshi H, Reardon M, Rodriguez R, H. Rogers YH, Romblad D, Ruhfel B, Scott R, Sitter C, Smallwood M, Stewart E, Strong R, Suh E, Thomas R, N. Tint NN, Tse S, Vech C, Wang G, Wetter J, Williams S, Williams M, Windsor S, Winn-Deen E, Wolfe K, Zaveri J, Zaveri K, Abril JF, Guigo R, Campbell MJ, Sjolander KV, Karlak B, Kejariwal A, Mi H, Lazareva B, Hatton T, Narechania A, Diemer K, Muruganujan A, Guo N, Sato S, Bafna V, Istrail S, Lippert R, Schwartz R, Walenz B, Yooseph S, Allen D, Basu A, Baxendale J, Blick L, Caminha M, Carnes-Stine J, Caulk P, Chiang YH, Coyne M, Dahlke C, Mays A, Dombroski M, Donnelly M, Ely D, Esparham S, Fosler C, Gire H, Glanowski S, Glasser K, Glodek A, Gorokhov M, Graham K, Gropman B, Harris M, Heil J, Henderson S, Hoover J, Jennings D, Jordan C, Jordan J, Kasha J, Kagan L, Kraft C, Levitsky A, Lewis M, Liu X, Lopez J, Ma D, Majoros W, McDaniel J, Murphy S, Newman M, Nguyen T, Nguyen N, Nodell M, Pan S, Peck J, Peterson M, Rowe W, Sanders R, Scott J, Simpson M, Smith T, Sprague A, Stockwell T, Turner R, Venter E, Wang M, Wen M, Wu D, Wu M, Xia A, Zandieh A, Zhu X. 2001. The sequence of the human genome. Science 291: 1304-1351.
65. Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL, Brownstein BH, Collins FS. 1990. Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients. Science 249:181-186.
66. Williams R, Threadgill D, Airey D, Gu J, Lu L. 2001. RIX Mapping: A demonstration using CXB RIX hybrids to map QTLs modulating brain weight in mice. Soc Neurosci Abstr
67. Zhang S, Ramsay ES, Mock BA. 1998. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctrl. Proc Natl Acad Sci U S A 95:2429-2434.